Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control
Open Access
- 1 October 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 66 (780) , 860-861
- https://doi.org/10.1136/pgmj.66.780.860
Abstract
Summary: We report three patients who had serious disturbance of anticoagulant control while receiving ifosfamide/mesna-containing cytotoxic chemotherapy in association with warfarin. In view of the likely biological potentiation of warfarin by ifosfamide/mesna, close monitoring of anticoagulant control should be performed during the co-administration of these drugs.Keywords
This publication has 6 references indexed in Scilit:
- COMPARATIVE PHARMACOKINETICS AND ALKYLATING ACTIVITY OF FRACTIONATED INTRAVENOUS AND ORAL IFOSFAMIDE IN PATIENTS WITH BRONCHOGENIC-CARCINOMA1989
- THROMBOEMBOLIC EVENTS DURING COMBINATION CHEMOTHERAPY FOR GERM CELL MALIGNANCYThe Lancet, 1988
- Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.BMJ, 1988
- Ifosfamide.1988
- QUANTITATION BY GAS CHROMATOGRAPHY CHEMICAL IONIZATION MASS-SPECTROMETRY OF CYCLOPHOSPHAMIDE, PHOSPHORAMIDE MUSTARD, AND NORNITROGEN MUSTARD IN PLASMA AND URINE OF PATIENTS RECEIVING CYCLOPHOSPHAMIDE THERAPY1978
- The effect of cytotoxic agents on drug metabolismPublished by Elsevier ,1970